We are live on
!
Find out more
Bank Julius Baer & Co Portfolio holdings
AUM
$38.6B
1-Year Est. Return
35.31%
This Fund
S&P 500
This Quarter
Est. Return
+4.53%
1 Year Est. Return
+35.31%
3 Year Est. Return
+114.04%
5 Year Est. Return
+141.38%
10 Year Est. Return
–
AUM
$13.4B
AUM Growth
+$1.17B
(+9.6%)
Cap. Flow
+$978M
Cap. Flow
% of AUM
7.33%
Top 10 Holdings %
Top 10 Hldgs %
32.99%
Holding
925
New
124
Increased
306
Reduced
365
Closed
113
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$137M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$104M |
| 3 |
Carrier Global
CARR
|
+$104M |
| 4 |
UnitedHealth
UNH
|
+$99.3M |
| 5 |
NextEra Energy
NEE
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$94.1M |
| 2 |
Mastercard
MA
|
+$93.1M |
| 3 |
Visa
V
|
+$75.8M |
| 4 |
Cadence Design Systems
CDNS
|
+$70.9M |
| 5 |
3M
MMM
|
+$69.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.73% |
| 2 | Healthcare | 16.05% |
| 3 | Financials | 12.84% |
| 4 | Communication Services | 8.96% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HGEN
726
DELISTED
HUMANIGEN, INC.
HGEN
| $29K | ﹤0.01% |
+1,500
| New | +$27.4K |
|
727
Baker Hughes
BKR
$63.1B
| $28K | ﹤0.01% |
1,286
-9
| -0.7% | -$205 |
|
728
TotalEnergies
TTE
$194B
| $28K | ﹤0.01% |
599
+2
| +0.3% | +$91 |
|
729
Jefferies Financial Group
JEF
$12.9B
| $27K | ﹤0.01% |
936
+1
| +0.1% | +$27 |
|
730
NetEase
NTES
$84.9B
| $27K | ﹤0.01% |
+264
| New | +$29.9K |
|
|
NVTA
731
DELISTED
Invitae Corporation
NVTA
| $27K | ﹤0.01% |
700
-29,891
| -98% | -$1.36M |
|
732
Fluor
FLR
$7.5B
| $25K | ﹤0.01% |
1,100
-27
| -2% | -$525 |
|
|
HEPA
733
DELISTED
Hepion Pharmaceuticals
HEPA
| $24K | ﹤0.01% |
13
+5
| +63% | +$11K |
|
|
BTWNU
734
DELISTED
Bridgetown Holdings Limited Units
BTWNU
| $24K | ﹤0.01% |
2,000
-2
| -0.1% | -$30 |
|
735
Canadian Natural Resources
CNQ
$97.4B
| $23K | ﹤0.01% |
1,532
+5
| +0.3% | +$68 |
|
|
DFS
736
DELISTED
Discover Financial Services
DFS
| $23K | ﹤0.01% |
245
+2
| +0.8% | +$189 |
|
737
iShares ESG Aware MSCI USA ETF
ESGU
$18.4B
| $23K | ﹤0.01% |
+256
| New | +$22.8K |
|
738
Exelixis
EXEL
$13B
| $23K | ﹤0.01% |
+1,000
| New | +$22.6K |
|
739
Inovio Pharmaceuticals
INO
$72.9M
| $23K | ﹤0.01% |
208
-206
| -50% | -$27.1K |
|
740
Arbutus Biopharma
ABUS
$907M
| $22K | ﹤0.01% |
6,500
+21
| +0.3% | +$81 |
|
741
Actinium Pharmaceuticals
ATNM
$24.3M
| $22K | ﹤0.01% |
2,848
-1,255
| -31% | -$10.7K |
|
742
JFrog
FROG
$10.7B
| $22K | ﹤0.01% |
500
-3,002
| -86% | -$173K |
|
|
BLDP
743
Ballard Power Systems
BLDP
$772M
| $21K | ﹤0.01% |
845
-211,035
| -100% | -$6.31M |
|
744
FNB Corp
FNB
$6.72B
| $20K | ﹤0.01% |
+1,555
| New | +$18K |
|
745
iShares US Oil Equipment & Services ETF
IEZ
$378M
| $20K | ﹤0.01% |
+1,500
| New | +$20.2K |
|
746
NovoCure
NVCR
$2.02B
| $20K | ﹤0.01% |
+150
| New | +$23.7K |
|
747
Oscar Health
OSCR
$8.74B
| $20K | ﹤0.01% |
+750
| New | +$23.5K |
|
748
Yum! Brands
YUM
$40B
| $20K | ﹤0.01% |
181
-3
| -2% | -$318 |
|
|
ME
749
DELISTED
23andMe Holding Co
ME
| $20K | ﹤0.01% |
+100
| New | +$24.4K |
|
|
MYOV
750
DELISTED
Myovant Sciences Ltd.
MYOV
| $20K | ﹤0.01% |
963
-123
| -11% | -$2.8K |
|
Similar funds
Bank Julius Baer & Co's Q1 2021 Portfolio in Review
As of Q1 2021, Bank Julius Baer & Co held 925 positions worth $13.4B, up 9.6% from $12.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Bank Julius Baer & Co deployed $978M of net new capital in Q1 2021, opening 124 new positions and adding to 306 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 1,254,550 shares worth $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Salesforce, an estimated $94.1M trimmed.
- Bank Julius Baer & Co's largest Q1 2021 buy was Vanguard Short-Term Corporate Bond ETF: 1,254,550 shares worth $104M.
- Bank Julius Baer & Co added most to JPMorgan Chase in Q1 2021, an estimated $137M increase.
- Bank Julius Baer & Co's biggest Q1 2021 reduction was Salesforce, cutting an estimated $94.1M.
- Bank Julius Baer & Co fully exited Invesco Equal Weight 0-30 Year Treasury ETF in Q1 2021, selling an estimated $12.1M.
- Bank Julius Baer & Co's ten largest holdings make up 33% of its $13.4B portfolio in Q1 2021.
- Bank Julius Baer & Co opened 124 new positions and closed 113 in Q1 2021.
- Bank Julius Baer & Co's portfolio value rose 9.6% quarter-over-quarter to $13.4B.
Based on Bank Julius Baer & Co's 13F filing for Q1 2021, filed 10 May 2021.